State Financial Officers Backed PBM Fee Disclosure Rule

Twelve officials pledged to support new transparency requirements for pharmacy benefit managers in a letter to the DOL.

Updated on Oct. 2, 2026 in Healthcare

Isometric editorial illustration of medical pill bottles and a metallic ledger, representing regulatory transparency in healthcare. — Twelve state financial officers urged the Department of Labor to finalize new rules requiring increased fee disclosure from pharmacy benefit managers. AI Illustration. Upload story photo >

Live Poll

Should the government mandate greater transparency for pharmacy benefit manager fee disclosures?

Twelve state financial officers have sent a formal letter to the Department of Labor pledging support for a proposed rule requiring greater fee disclosure from pharmacy benefit managers (PBMs). The officials intend to use their state positions to advocate for the implementation of these transparency standards.

Why it matters

The signers argue that hidden PBM fees create inefficiencies that negatively impact state finances and public pension funds. By pushing for increased oversight, they aim to lower healthcare costs for taxpayers, employees, and businesses across the country.

Twelve state financial officers have committed to pushing for compliance with the Department of Labor rule. This group represents officials from various states, including Indiana, Kentucky, Louisiana, Montana, Nebraska, North Dakota, South Carolina, Utah, West Virginia, and Wyoming.

The players

Department of Labor

This federal agency is responsible for proposing and enforcing labor and employment regulations, including those governing pharmacy benefit manager disclosure requirements.

State Financial Officers Foundation

This organization promotes the interests of state financial officers and expects that finalizing the proposed PBM rule will result in a significant domestic policy achievement.

The details

The coalition of state officers is encouraging the Department of Labor to finalize its January 2026 proposal aimed at shedding light on opaque pharmacy benefit management practices. The State Financial Officers Foundation views the potential expansion of these transparency requirements as a major milestone for domestic economic policy.

The Department of Labor issued its proposed PBM fee disclosure rule in January 2026.
Twelve state financial officers sent a formal letter of support on October 2, 2026.

Market Landscape

The push by state officers follows the Department of Labor's 2026 PBM fee disclosure proposal, which aims to curb opacity in the pharmaceutical supply chain. This coordination signals a broader trend of state-level fiscal authorities attempting to assert more control over institutional healthcare spending.

For taxpayers and employees, the adoption of these disclosure rules could lead to reduced healthcare costs by making PBM fee structures more transparent. The move is designed to ensure that state pension funds and public budgets are better protected from hidden industry charges.

The takeaway

The active involvement of state financial officers demonstrates how fiscal policy is increasingly being used to target healthcare transparency. Residents should monitor local legislative sessions for further efforts by these offices to advocate for similar oversight at the state level.